HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Abhijat Kitchlu Selected Research

pembrolizumab

10/2022Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer.
10/2017Nephrotic Syndrome With Cancer Immunotherapies: A Report of 2 Cases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Abhijat Kitchlu Research Topics

Disease

23Neoplasms (Cancer)
05/2024 - 10/2017
20Acute Kidney Injury (Acute Renal Failure)
05/2024 - 05/2011
8Chronic Renal Insufficiency
05/2024 - 04/2014
4Interstitial Nephritis (Tubulointerstitial Nephritis)
05/2024 - 01/2020
3Chronic Kidney Failure (Chronic Renal Failure)
06/2023 - 01/2021
3Thrombotic Microangiopathies
11/2022 - 01/2021
3Critical Illness (Critically Ill)
01/2021 - 04/2014
2Amyloid Plaque
01/2023 - 01/2020
2Carcinoma (Carcinomatosis)
01/2023 - 01/2021
2Amyloidosis
01/2023 - 01/2020
2Hypertension (High Blood Pressure)
05/2022 - 01/2022
2Proteinuria
05/2022 - 10/2017
2Kidney Neoplasms (Kidney Cancer)
01/2021 - 01/2020
2Hyponatremia
01/2020 - 01/2019
1Drug-Related Side Effects and Adverse Reactions
11/2023
1Myocardial Infarction
02/2023
1Lung Neoplasms (Lung Cancer)
10/2022
1Kaposi Sarcoma (Kaposi's Sarcoma)
05/2022
1Skin Neoplasms (Skin Cancer)
02/2022
1Hematologic Diseases (Blood Diseases)
01/2022
1Genetic Predisposition to Disease (Genetic Predisposition)
11/2021
1Atrial Fibrillation
10/2021
1Prostatic Neoplasms (Prostate Cancer)
03/2021
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2021
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2021
1Renal Cell Carcinoma (Grawitz Tumor)
01/2021
1Type 2 Diabetes Mellitus (MODY)
01/2021
1Glomerulonephritis
01/2021
1Infections
01/2021
1Ketosis
01/2021
1Vasculitis (Vasculitides)
01/2021
1Cardiac Arrhythmias (Arrythmia)
01/2020
1Heart Failure
01/2020
1Cytokine Release Syndrome
01/2020
1Tumor Lysis Syndrome
01/2020
1Paraproteinemias (Monoclonal Gammopathy)
01/2020
1Disease Progression
01/2020
1Hematologic Neoplasms (Hematological Malignancy)
01/2020
1Testicular Neoplasms (Testicular Cancer)
10/2019
1Lymphoma (Lymphomas)
06/2019
1Nephrotic Syndrome (Syndrome, Nephrotic)
10/2017
1Melanoma (Melanoma, Malignant)
10/2017
1Hodgkin Disease (Hodgkin's Disease)
10/2017
1Autosomal Dominant Polycystic Kidney (ADPKD)
06/2017

Drug/Important Bio-Agent (IBA)

9Immune Checkpoint InhibitorsIBA
05/2024 - 01/2020
7CreatinineIBA
05/2024 - 10/2019
6Cisplatin (Platino)FDA LinkGeneric
05/2024 - 06/2019
5ElectrolytesIBA
06/2023 - 01/2020
2Prealbumin (Transthyretin)IBA
01/2023 - 01/2020
2pembrolizumabIBA
10/2022 - 10/2017
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 10/2017
2SodiumIBA
01/2021 - 01/2020
2Proteins (Proteins, Gene)FDA Link
01/2020 - 10/2017
2SteroidsIBA
01/2020 - 05/2015
1PlatinumIBA
05/2024
1Glucagon-Like Peptide 1 (GLP 1)IBA
11/2023
1Cardiovascular AgentsIBA
02/2023
1Amyloid (Amyloid Fibrils)IBA
01/2023
1liposomal doxorubicin (Doxil)FDA Link
05/2022
1AlbuminsIBA
01/2022
1apixabanIBA
10/2021
1Warfarin (Coumadin)FDA LinkGeneric
10/2021
1RivaroxabanIBA
10/2021
1AnticoagulantsIBA
10/2021
1DabigatranFDA Link
10/2021
1AntibodiesIBA
09/2021
1Bevacizumab (Avastin)FDA Link
01/2021
1Complement C3 (C3 Complement)IBA
01/2021
1Glucose (Dextrose)FDA LinkGeneric
01/2021
1Paclitaxel (Taxol)FDA LinkGeneric
01/2021
1Angiogenesis InhibitorsIBA
01/2021
1Chimeric Antigen ReceptorsIBA
01/2020
1Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
01/2020
1Mannitol (Osmitrol)FDA LinkGeneric
06/2019
1MagnesiumIBA
06/2019
1Vitamin KFDA Link
01/2019
1DiureticsIBA
01/2019
1Angiotensin Receptor AntagonistsIBA
01/2019
1Vasopressins (Vasopressin)IBA
01/2019
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2019
1CTLA-4 AntigenIBA
10/2017
1IpilimumabIBA
10/2017
1Anti-Bacterial Agents (Antibiotics)IBA
05/2015

Therapy/Procedure

20Therapeutics
05/2024 - 06/2017
6Drug Therapy (Chemotherapy)
05/2024 - 01/2018
4Kidney Transplantation
05/2022 - 01/2018
3Continuous Renal Replacement Therapy
01/2021 - 04/2014
2Immunotherapy
05/2024 - 10/2017
2Aftercare (After-Treatment)
05/2022 - 01/2022
2Organ Transplantation
02/2022 - 01/2021
2Transplantation
02/2022 - 01/2021
2Hybrid Renal Replacement Therapy
01/2021 - 08/2015
1Combination Drug Therapy (Combination Chemotherapy)
05/2024
1Time-to-Treatment
11/2023
1Cell Transplantation
01/2022
1Duration of Therapy
01/2022
1Nephrectomy
01/2021
1Neoadjuvant Therapy
01/2021
1Home Nursing (Nursing, Home)
01/2018
1Patient Readmission
01/2017